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Abstract
Several Ca
2+-permeable channels, including the non-selective cation channel TRPV4, are subject to Ca
2+-dependent
facilitation. Although it has been clearly demonstrated in functional experiments that calmodulin (CaM) binding to
intracellular domains of TRP channels is involved in this process, the molecular mechanism remains elusive. In this study, we
provide experimental evidence for a comprehensive molecular model that explains Ca
2+-dependent facilitation of TRPV4. In
the resting state, an intracellular domain from the channel N terminus forms an autoinhibitory complex with a C-terminal
domain that includes a high-affinity CaM binding site. CaM binding, secondary to rises in intracellular Ca
2+, displaces the N-
terminal domain which may then form a homologous interaction with an identical domain from a second subunit. This
represents a novel potentiation mechanism that may also be relevant in other Ca
2+-permeable channels.
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Introduction
Ca
2+-dependent regulation by calmodulin (CaM) has been
demonstrated for a large number of intracellular proteins
including Ca
2+-permeable plasma membrane cation channels.
Often, this provides a negative feedback mechanism that either
prevents excessive, potentially deleterious Ca
2+ influx into the cell,
or defines the time course of channel activity. Indeed, CaM-
dependent inhibition is seen in most of the non-selective, Ca
2+-
permeable cation channels of the TRP group [1,2,3,4,5]. Within
the TRPV subfamily, CaM-dependent regulation has been shown
for the capsaicin and temperature-sensitive TRPV1 [3,6,7],
temperature-sensitive TRPV3 [8], the highly Ca
2+-selective
epithelial Ca
2+ channels TRPV5 and TRPV6 [4,9,10], and
TRPV4 [11].
TRPV4 is highly expressed in kidney and was originally found
to be activated by hypotonic solutions, suggesting a role in renal
osmoregulation [12,13,14]. Studies thereafter identified multiple
other stimuli (phorbol esters, temperature [15,16], mechanical
stimulation [17,18,19,20,21,22] and arachidonic acid metabolites
[23,24]) and localizations suggesting diverse modes of activation in
sensory and other systems. Like other TRP channels, TRPV4 is
subject to dual Ca
2+-dependent regulation with channel activity
being potentiated and inactivated at Ca
2+ concentrations attained
during agonist-dependent activation [11,25]. Ca
2+-dependent
facilitation has also been described for TRPC5 [26], TRPV3
[8], TRPV6 [9] and TRPA1 [27,28].
In a previous study, we identified a CaM binding domain in the
C terminus of TRPV4 as the structural basis of the Ca
2+-
dependent potentiation process [11]. Although CaM binding is a
prerequisite for potentiation, the molecular mechanism that
couples CaM binding to enhanced channel activity has not been
resolved. Using protein interaction experiments and functional
assays, we show that the molecular correlate of Ca
2+-dependent
current potentiation is disruption of an interdomain interaction
within TRPV4 resulting from CaM binding to a C-terminal site.
We provide experimental evidence for an underlying mechanism
in which an N-terminal autoinhibitory domain forms a molecular
switch that controls facilitation of TRPV4.
Results and Discussion
The C-terminal CaM binding site in TRPV4 binds to the
CaM C lobe
Because CaM interaction with a C-terminal binding site in
TRPV4 has been shown to be an essential step in the Ca
2+-
dependent potentiation of TRPV4 [11], we attempted to obtain
initial clues about the underlying molecular mechanism by
studying the CaM binding geometry. We analyzed the properties
of the complex between CaM and C-terminal fragments of the
human TRPV4 ortholog, and investigated the structural determi-
nants within the CaM molecule that are involved in binding.
Fluorescence polarization experiments with the carboxyfluor-
escein-labeled CaM binding peptide, P5, as the tracer molecule
(Fig. 1A, Table S1), showed that CaM binding was Ca
2+-
dependent and half-maximal at 3.2 mMC a
2+ (Fig. 1C). Thus, in
contrast to some other TRP channels, where CaM binding is
present at nanomolar Ca
2+ concentrations [4,29], CaM binding to
TRPV4 depends on Ca
2+ concentrations above those in resting
cells. The Ca
2+ concentration at which CaM binding to P5 was
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TRPV4 by intracellular Ca
2+ in electrophysiological experiments
(around 600 nM, [25]). However, during the dynamic response to
an agonist, potentiation via this CaM binding site clearly precedes
the inactivation process [11]. A possible explanation for the
apparent discrepancy in the Ca
2+ dependencies is that CaM
binding to the full-length channel may occur at lower concentra-
tions than to the short fragment used here. Alternatively,
inactivation may be more sensitive to Ca
2+, but a slower process
than potentiation, or, in the case e.g. of Ca
2+ entry through the
channel, components of the potentiatory process may be exposed
to a higher local Ca
2+ concentration than those involved in
inactivation.
A characteristic feature of the CaM molecule is its symmetry
with respect to its domain composition. The homologous N- and
C-terminal lobes that both comprise two Ca
2+-binding EF hand
motifs (Fig. 1B), each expose a hydrophobic interaction domain on
the molecular surface secondary to Ca
2+ binding and may thus
contribute independently to target binding. To quantify the
individual affinities of the isolated CaM lobes to P5, we performed
P5 fluorescence polarization experiments at different lobe
concentrations in 100 mMC a
2+ (Fig. 1D). The Kd values were
400 nM, 700 nM and 25 mM for CaM and the CaM C-terminal
(CaM-C) and N-terminal (CaM-N) lobes, respectively, indicating a
36-fold higher affinity of the CaM C lobe over the N lobe. In an
independent experimental approach, we subjected a longer C-
terminal TRPV4 fragment, C2 (Fig. 1A), to a CaM interaction
assay that is based on the AlphaScreen proximity assay technology
(Fig. 2, Fig. S1, Methods S1). Using different CaM constructs, we
analyzed the relative binding affinities of the two CaM lobes alone
Figure 1. Lobe-specific CaM binding to TRPV4-C2. (A) TRPV4 topology. Ankyrin domains, transmembrane helices and the C-terminal CaM
binding site associated with Ca
2+-dependent potentiation are shown as black, white and grey boxes in the linearized TRPV4 structure. The positions
of the protein fragments, peptides P1–5 and the N-terminal mutations (asterisk) used in this study are indicated below. For the precise positions see
Table S1 (B) Structure of the CaM molecule. The EF hand domains 1 to 4 are shown as white boxes and the positions of the homologous lobe
fragments used for the interaction experiments are indicated. (C) Ca
2+-dependence of CaM binding to the fluorophore-labeled P5 peptide measured
by fluorescence polarization. (D) Binding of the individual CaM lobes to fluorophore-labeled P5 peptide at 100 mMC a
2+. (E) Binding to the C2
fragment of the CaM lobes or CaM mutants that are lobe-specifically (CaM12, CaM34) or fully (CaM1234)C a
2+ binding-deficient (4 independent
experiments, p#0.001). (F) In HEK293 cells coexpressing TRPV4 and the indicated CaM mutants, whole-cell currents were activated by the application
of 4a-PMA in Ca
2+-free bath solutions. Current increases at +100 mV and 2100 mV were measured after addition of 2 mM Ca
2+ and compared to
CaM overexpression (p=0.013 and 0.007, respectively, for CaM12).
doi:10.1371/journal.pone.0010580.g001
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2+ binding-deficient in the N-lobe
(CaM12), C-lobe (CaM34) or both lobes (CaM1234) at 100 mMC a
2+
(Fig. 1E). Again, the interaction signal was found to be highly
dependent on the presence of the functional C-lobe (Fig. 1E). The
Ca
2+-dependence of the interaction was similar for CaM, CaM12
and CaM34 with EC50 Ca
2+ concentrations of 8.861.0 mM,
10.761.0 mM, 27.061.1 mM, respectively (Fig. S2).
To assess whether this finding is functionally relevant, we tested
the effect of overexpression of CaM and CaM mutants on TRPV4
activity. In nominally Ca
2+-free solutions, activation of TRPV4 by
the phorbol ester 4a-PMA, a partial TRPV4 agonist [30]that we
used in a previous study [11], is weak and slow. Addition of Ca
2+
after activation by 4a-PMA results in facilitation followed by
inactivation of the channel [11]. We measured the current
increase on adding Ca
2+ (2 mM) in HEK293 cells expressing
YFP (not shown) or TRPV4 alone (control), or TRPV4 together
with CaM or CaM mutants (Fig. 1F). CaM or the CaM mutants
had no effect on spontaneous currents, or currents activated by 4a-
PMA in a nominally Ca
2+-free solution (not shown). A current
increase upon addition of Ca
2+ was observed in all cells except
those expressing YFP alone. In the latter, currents were not
significantly changed at +100 mV (difference: 0.13360.438 pA/
pF, n=8, p=0.7688), but significantly decreased at -100 mV
(difference-1.09760.436 pA/pF, n=8, p=0.04), probably due to
a decrease in leakage current. CaM slightly increased the TRPV4
response to Ca
2+, but the increase is not statistically significant,
indicating that in HEK cells, the CaM concentration is not a
limiting factor in TRPV4 potentiation. CaM mutants with a
dysfunctional C lobe (CaM34, CaM1234) had no effect (Fig. 1F),
probably because these mutants do not interact with the TRPV4
C-terminal domain and do not functionally compete with
endogenous CaM. In contrast, current increases were significantly
smaller with the mutant CaM12 that binds to TRPV4. This
mutant may bind and displace endogenous CaM, but, owing to
the N-terminal mutation, cannot fully substitute for the wild type
molecule. This suggests that, in spite of its lower affinity to the C-
terminal CaM binding site in TRPV4, the CaM N lobe
contributes functionally to TRPV4 potentiation by a mechanism
which remains unclear.
These results with CaM mutants differ from those on Ca
2+-
dependent potentiation in other TRP channels. Coexpression of
CaM1234 abolished TRPC6 activation secondary to Gq protein-
coupled receptor activation or diacylglycerol application [31,32]
and strongly decreased activation of the adenosine diphosphor-
ibose-sensitive channel TRPM2 [33,34]. For TRPM2, co-
immunoprecipitation experiments demonstrated CaM1234 binding
to the channel, indicating that Ca
2+-independent CaM binding
contributes to the facilitation mechanism. In contrast to these
findings, TRPV4 neither binds to CaM in Ca
2+-free buffers, nor to
CaM1234, and potentiation of its activity directly depends on CaM
interaction triggered by a rise in Ca
2+.
How does CaM binding facilitate Ca
2+ entry through TRPV4
at the molecular level? Two general molecular switching
mechanisms seemed conceivable. The first comprises a ternary
interaction in which Ca
2+-loaded CaM binds to two different sites
within the TRPV4 protein thus bringing two regulatory domains
in proximity to each other. Indeed, asymmetrical CaM binding
has been demonstrated for the pore-forming subunits of the
CaV1/CaV2 [35,36] and SK [37,38] channel families, and a
similar mechanism has been proposed for the Ca
2+-dependent
desensitization of TRPV1 [6,7]. Using CaM overlay experiments
on a peptide library representing the cytosolic termini of TRPV4
and fluorescence polarization experiments we identified three
additional CaM binding sites in TRPV4 that may serve as
anchoring domains for the CaM N lobe (Fig. S3). However, in
fluorescence polarization experiments, their CaM affinities were in
the micromolar range (Fig. S4) and none bound to CaM-N with
higher affinity than to CaM-C (Table S2).
CaM binding disrupts an interdomain interaction
The alternative scenario for CaM-dependent current facilitation
in TRPV4 involves a disinhibition process in which CaM binding
displaces a regulatory domain that is attached to TRPV4 in the
resting state. Prototypical mechanisms involving the displacement
of autoinhibitory domains from a functional center are found in
the CaM-dependent activation of CaMK II [39] and the plasma
membrane Ca
2+ pump [40,41]. Multiple lines of evidence indicate
that this is indeed the mechanism of the CaM-dependent
potentiation in TRPV4.
First, we did a complementation experiment to test whether a
CaM molecule that binds to the C2 fragment of TRPV4 through
its C-lobe can form an additional interaction with another CaM
binding domain thus forming a ternary complex. We focused on
the N-terminal P2 peptide which with its accumulation of
positively charged amino acids around a central tryptophan
residue resembles the CaM-binding M13 peptide from the skeletal
muscle myosin light chain kinase, a prototypical CaM binding
motif. We used an AlphaScreen-based proximity assay (Fig. 2,
Methods S1) in which the acceptor beads were coated with the C-
terminal fragment C2-Flag, and the donor beads either with the
N-terminal CaM binding peptide P2-biotin, or, as a negative
control, with C2-biotin. The interaction between the proteins was
measured in the presence of increasing CaM concentrations in
100 mMC a
2+ or 1 mM EGTA (Fig. 3A). Surprisingly, instead of
CaM-dependent complex formation, a strong constitutive inter-
action between the N- and C-terminal TRPV4 fragments was
observed in the absence of CaM (Fig. 3A). CaM competitively
reduced this interaction in a Ca
2+-dependent fashion with an IC50
of 166 nM in 100 mMC a
2+, a value that is in agreement with the
Kd observed for its binding to C2 (see Fig. 1D). The control
reaction in which both acceptor and donor beads were coated with
the C2 protein did not show interaction in the absence or presence
of CaM (Fig. 3A).
To determine the Ca
2+-dependence of the complex between P2
and C2, an AlphaScreen experiment was performed in the
absence of CaM but with Ca
2+ concentrations between 10 nM
and 10 mM (Fig. 3B). The interaction was already present at 0
Ca
2+ and essentially Ca
2+-insensitive over a wide range of Ca
2+
Figure 2. AlphaScreen-based CaM interaction assay. Optical
stimulation of phthalocyanine compounds contained in the AlphaSc-
reen donor beads excites ambient oxygen molecules into the
metastable singlet state. The energy conveyed by the molecule is
converted into light emission by the acceptor bead. Owing to the
limited lifespan of singlet oxygen in solution, the AlphaScreen signal
emission is highly dependent on the distance between the two beads.
In this study, AlphaScreen donor and acceptor beads were modified for
the detection of CaM/TRPV4 or interdomain interactions. Streptavidin-
coated donor and anti-Flag acceptor beads were used to attach the
proteins to the bead surface.
doi:10.1371/journal.pone.0010580.g002
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2+ concentrations above 100 mM,
however, inhibited binding of the fragments, a process that is
probably secondary to unspecific Ca
2+ binding and has been
observed for other protein interactions including CaM binding to
TRPV4 [11].
To more finely map the interaction site, we then performed
overlay experiments with a partial peptide library from the
TRPV4 N terminus (Fig. S3A). Probing with the C2 fragment
resulted in strong binding to a site that overlaps with the P2
peptide. In a similar fashion, a peptide array from the TRPV4 C
terminus was probed with the N-terminal N3 fragment (Fig. 1A)
that includes P2 (Fig. S3B). Consistent with the finding that CaM
inhibits the interaction, strong interaction was found with a region
that corresponds to the CaM binding peptide P5.
The interdomain interaction could also be shown using the
longer N-terminal TRPV4 fragments N2 (wt in Fig. 3C) and N3
(data not shown) instead of P2. In an AlphaScreen interaction
experiment, donor and acceptor beads were incubated with
10 nM C2-biotin and N2-Flag at concentrations ranging from
30 pM to 1.5 mM, respectively (Fig. 3C). Increasing N2-Flag
concentrations resulted in increasing C2 interaction signals with a
maximum at the bead capacity of approximately 10 nM bound
protein. Further increases in the N2-Flag concentration led to
signal reduction owing to a hook effect of the assay system,
demonstrating specific interaction of the fragments (see Methods
S1).
Secondly, N2 mutants in which key basic amino acids within the
N-terminal binding motif were changed into alanine showed
significantly weaker binding to C2. We used site-directed
mutagenesis to create N2 mutants that lack either the hydrophobic
(WIA) or the positively charged residues (KRA) in the N-terminal
interaction domain (Fig. 3D). In AlphaScreen-based C2 interac-
tion assays, both constructs, WIA and KRA, had a significantly
lower binding affinity to the C2 fragment (Fig. 3C,E) with
Figure 3. The C2 fragment interacts with an N-terminal domain. (A) P2 and CaM bind competitively to C2. C2-Flag interaction with P2-biotin
(squares) or, as control protein, C2-biotin (circles) was measured in an AlphaScreen interaction assay in the presence of CaM at the indicated
concentrations or in the absence of CaM (control). Buffers contained either 100 mMC a
2+ (filled symbols) or 1 mM EGTA (open symbols). A strong
constitutive interaction between C2 and P2 was observed that was inhibited by Ca
2+/CaM. (B) The C2-P2 interaction is Ca
2+-independent over a wide
range of Ca
2+ concentrations. (C and D) Mutation of specific amino acids in the N-terminal binding domain abolishes the interdomain interaction.
Binding of C2-biotin to the N2-Flag (wt) or the mutants N2-WIA and N2-KRA given in D was measured at concentrations between 10 pM and 1 mMi n
buffers containing 100 mMC a
2+. (E) Curve maxima from C were tested against wild type. Both mutants showed significantly lower interaction signals
(p,0.0001, 5 independent experiments).
doi:10.1371/journal.pone.0010580.g003
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the wild type at the given component concentrations.
The same was found when CFP- and YFP- fusion protein of the
full-length N and C-termini, respectively, (N1, C1, Fig. 1A) were
tested for interaction in fluorescence resonance energy transfer
(FRET) experiments after coexpression in HEK293 cells (Fig. 4).
This is in agreement with a recent study [42] that showed high
FRET efficiency in TRPV4 for both homologous N-terminal and
N-terminal to C-terminal interactions. Interestingly, the interac-
tion site represented by the P2 peptide is close to a proline-rich
domain that has been shown to interact with PACSIN 3, a
regulatory protein that controls basal TRPV4 activity and stimulus
specificity [43,44].
To investigate the interaction in the full-length channel protein,
we used a TRPV4 expression construct in which CFP and YFP
were fused to the N- and C termini, respectively (Fig. 5).
Fluorescence resonance energy transfer (FRET) experiments in
unstimulated HEK293 cells expressing the construct revealed a
significantly stronger FRET efficiency between the fluorophores
than in cells cotransfected with a TRPV4-CFP fusion construct
and YFP (Fig. 5A,B). The same was found in cells cotransfected
with CFP-TRPV4 and TRPV4-YFP (Fig. 5B) suggesting that
interactions can occur between subunits in the homotetrameric
channel. All constructs resulted in functional channels (data not
shown). Interestingly, both stimulation of CFP-TRPV4-YFP by
decreases in the extracellular osmolarity (Fig. 5C) or application of
4a-PMA (not shown) in Ca
2+-containing buffer, and intracellular
Ca
2+ release after stimulation of the endogenous M3 muscarinic
receptor resulted in transient decreases in the FRET- and
concomitant increases in the donor channel fluorescences,
indicating a decrease in FRET efficiency (Fig. 5C).
Inhibition of the interaction between N and C termini
renders TRPV4 permanently potentiated
As a third line of evidence, the full-length WIA and KRA
mutants displayed significantly enhanced currents during activa-
tion in nominally Ca
2+-free media (Fig. 6). In whole-cell patch-
clamp experiments, TRPV4 wild type showed an initial decrease
in spontaneous activity after establishment of the whole cell
configuration (Fig. 6A). Addition of 4a-PMA thereafter in the
nominal absence of Ca
2+ led to a slow, small increase in currents
which after reaching a plateau were then strongly, but transiently
potentiated on readdition of Ca
2+. Potentiation was rapidly
followed by Ca
2+-dependent inhibition. Both mutants showed
clear differences to wild type TRPV4. Significantly larger currents
were activated by 4a-PMA in the nominally Ca
2+-free medium
and no potentiation, only inhibition was observed on readdition of
Ca
2+ (Fig. 6B, C). Interestingly, the current densities attained by
the mutants in 4a-PMA were similar to those for wild type TRPV4
after potentiation by Ca
2+. Thus, channels with the mutations that
prevent or reduce interactions between the N and C termini do
not require increases in intracellular Ca
2+ for strong current
activation.
All data provide strong evidence for an interaction in TRPV4
between an N-terminal domain represented by the P2 peptide and
a site in the C terminus, P5, that also binds to CaM. Our
functional data show that disruption of the interaction by
mutagenesis of key amino acids leads to constitutive current
potentiation when the channel is stimulated in the absence of
extracellular Ca
2+. This is in good agreement with a previous
study [11] that demonstrated that TRPV4 mutants in which CaM
binding to the C terminus is abolished result in channels not
potentiated by Ca
2+ addition.
A similar interdomain interaction mechanism has also been
found in cyclic nucleotide-gated channels [45]. Here, an N-
terminal domain is capable of interacting with both the cyclic
nucleotide binding region in the C terminus of the protein and
Ca
2+/CaM. In contrast to TRPV4, however, this is functionally
coupled to autoregulatory channel inactivation. The same group
demonstrated using GFP-FRET experiments that the interaction
occurs between adjacent subunits of the tetrameric protein rather
than within the same subunit [46].
The N-terminal interaction domain is capable of
dimerization
When the chromatographically purified N2 protein was
subjected to SDS-PAGE, a strong band of the expected size of
34.8 kD was detected (Fig. 7A). In addition, a second band was
visible with a molecular weight compatible with a dimeric form of
N2 (Fig. 7A). In gel filtration experiments under non-denaturing
conditions, a single peak was detected at a size that corresponds to
the dimeric form (Fig. S5). We then used an AlphaScreen-based
assay to investigate the interaction of the N-terminal P2 peptide
with the wild type N2 fragment or the N2 mutants WIA and KRA
in nominally Ca
2+-free buffers (Fig. 7B). P2 bound strongly to wild
type N2 and the WIA mutant, but not to the KRA mutant. Similar
results were obtained using the biotinylated N2 fragment instead
of the P2 peptide (data not shown). These data show that the N-
terminal domain constituted by the P2 peptide, in addition to its
affinity for the C-terminal binding site, has the ability to form
homodimeric interactions.
FRET experiments were performed to validate the interaction
under intracellular conditions (Fig. 7C). N1-YFP was coexpressed
with N1-CFP or CFP alone in HEK293 cells and the donor
fluorescence measured during selective YFP photobleaching. The
respective maximal relative donor fluorescence increases after
acceptor bleaching were 1.2760.03 and 1.0460.01. We conclude
that there is significant interaction between two molecules of the
full-length TRPV4 N terminus that is dependent on the integrity
of the domain formed by the P2 peptide.
It is known that TRPV4 forms homotetrameric complexes [47].
The N termini of adjacent subunits are thus readily accessible for
homologous interaction. Indeed, previous studies [42] demon-
strated that strong binding between the N-terminal tails exists in
TRPV4. Studies in TRPV4 [48], TRPV5 [49] and TRPV6 [50]
indicated that specific N-terminal ankyrin domains are crucial
Figure 4. The TRPV4 N and C termini interact in HEK293 cells.
(A) YFP-fused C1 fragment and CFP-fused N1 (left) or CFP (right) were
coexpressed in HEK293 cells and the donor and acceptor fluorescences
(black and grey traces, respectively) measured during selective YFP
photobleaching (bar, 6 and 3 independent experiments). (B) FRET
acceptor bleaching measurements as shown in A were performed with
the indicated donor/acceptor combinations. YFP and CFP, respectively,
were used as acceptor and donor controls (3 independent experiments).
doi:10.1371/journal.pone.0010580.g004
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that includes the P2 peptide is located N-terminal to the ankyrin
domains (Fig. 1A). The dual affinity of this domain to both a
homologous domain of a second subunit and the C-terminal CaM
binding site suggests that it may contribute to transient rather than
static interactions in the functional channel.
Dual role of the N-terminal interaction domain
To investigate which of the alternative interactions of the P2
peptide is relevant in the absence and presence of CaM binding to
the TRPV4 C terminus, we performed a series of competition
experiments (Fig. 7D,E). AlphaScreen acceptor and donor beads
were coated with C2-Flag and either P2-biotin (Fig. 7D) or CaM-
biotin at 100 mMC a
2+ (Fig. 7E) and incubated with untagged C2
or N2 competitor proteins at the indicated concentrations. In the
P2/C2 complex (Fig. 7D), the IC50 values for C2 and N2 were
47 nM and 166 nM, respectively, indicating a 3.5-fold higher
apparent affinity of the C2 fragment. A similar finding was
observed when the CaM/C2 interaction was subjected to
competition by C2 or N2 (Fig. 7E). The IC50 values for C2 and
N2 were 38 nM and 522 nM. Taken together, the data indicate a
higher affinity of the N-terminal binding site towards C2 than to a
second N-terminal fragment, suggesting that in the resting state of
the channel when CaM is not bound to the C-terminal binding
site, the interaction between the N and C termini prevails.
In summary, this study provides a comprehensive model for
the Ca
2+-dependent potentiation of TRPV4 currents. Using
different experimental strategies, we have demonstrated that an
interaction between an N-terminal and a C-terminal site in
TRPV4 is present at nanomolar Ca
2+ concentrations (Fig. 8A),
but becomes disrupted secondary to CaM binding to the TRPV4
C terminus at micromolar Ca
2+ concentrations (Fig. 8B). In in
vitro FRET experiments, the interaction was shown to occur
between channel subunits, presumably in the channel homo-
tetramer. However, from the experimental data, we cannot
exclude the possibility that the N and C termini of a single
channel subunit can interact.
Evidence for an interaction between N and C termini was also
obtained in functional experiments. While TRPV4 mutants that
are CaM binding-deficient result in currents that are small and do
not potentiate secondary to rises in the intracellular Ca
2+
concentration [11], mutants in which the interaction is absent
result in large currents in the absence of Ca
2+ (Fig. 6). A second,
homologous interaction between the N termini of adjacent
TRPV4 subunits that is present when CaM is bound to the C-
terminal site may contribute to conformational changes that lead
to current facilitation (Fig. 8B), but we currently have no
functional evidence in support of this. This model represents a
new Ca
2+-dependent regulatory mechanism that may also be
found in other CaM-regulated cation channels.
Figure 5. Calcium-dependent interdomain interaction in TRPV4. (A) A CFP-TRPV4-YFP fusion construct (TRPV4) or TRPV4-YFP cotransfected
with CFP (control) were subjected to FRET acceptor bleaching experiments after expression in HEK293 cells. (B) FRET efficiencies were calculated by
the extrapolated donor increase at full acceptor photobleaching (three cells shown from each group). The FRET efficiencies from the experiments
shown in (A) (labeled C-V4-Y and control), and cells cotransfected with CFP-TRPV4 and TRPV4-YFP (labeled C2V4+V42Y), were 14.661.1, 2.060.8 and
19.661.9. Both CFP-TRPV4-YFP and CFP-TRPV4+TRPV4-YFP interactions were significantly different from control (inset, p,0.0001, n=7, 20 and 13,
respectively). (C) The donor and FRET channels were recorded in HEK293 cells expressing CFP-TRPV4-YFP during application of hypotonic medium
and 10 mM carbachol.
doi:10.1371/journal.pone.0010580.g005
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PLoS ONE | www.plosone.org 6 May 2010 | Volume 5 | Issue 5 | e10580Figure 6. TRPV4 mutations that disrupt the interaction between the N- and C-terminal domains result in channels that are strongly
activated in the absence of extracellular Ca
2+. (A–C) Time courses (left) of currents at -100 and +100 mV showing the activation by 4a-PMA (1 mM)
in a nominally Ca
2+-free solution (0 Ca
2+) and the effect of readdition of 2 mM Ca
2+ for wt TRPV4 (A) and the mutants WIA (B) and KRA (C). The IV-
relationships (right) were recorded in 4a-PMA just before and shortly after switching to 2 mM Ca
2+ as indicated by the arrows. (D) Mean current densities
at +100 and 2100 mV measured after break-in (basal) and at the start of 4a-PMA application in a nominally Ca
2+-free solution (0 Ca
2+), and the mean
maximum inward and outward current densities attained in 4a-PMA in the nominally Ca
2+-free solution, and following the addition of 2 mM Ca
2+ in 4a-
PMA (see numbers in A). The currents measured after stimulation in nominally Ca
2+-free solutions at -100 and +100 mV for the WIA (p=0.014 and 0.023)
and KRA mutants (p=0.012 and 0.007) were significantly larger than the wild type (n=9, 8 and 5 for wt, WIA and KRA).
doi:10.1371/journal.pone.0010580.g006
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AlphaScreen protein interaction measurements
Proteins were expressed in E. coli, affinity purified and
biotinylated if applicable (for details see Methods S1). For protein
interaction measurements, a proximity assay system based on the
AlphaScreen technology (PerkinElmer) was used (see Methods S1).
Briefly, streptavidin-coated AlphaScreen donor and anti-Flag
acceptor beads at a final concentration of 16.7 mg/ml were
incubated in a 384-well plate format (OptiPlate-384, PerkinElmer)
with C2-GST-biotin or P2-biotin and the respective Flag-tagged
interaction protein at concentrations of 10 nM, if not otherwise
indicated. Assay buffer conditions were 50 mM Tris, pH 7.4,
100 mM KCl, and 0.1% BSA. After incubation for 90 min at
room temperature, the AlphaScreen output signal was recorded in
a Fusion alpha FP instrument (PerkinElmer) at 2 s reading time
per well. AlphaScreen signals are given as mean6SEM in counts
per second (cps) units.
Fluorescence polarization
Tracer peptides were synthesized and coupled to carboxyfluor-
escein (Dr. Sven Rothemund, Core unit peptide technologies,
Figure 7. The P2 peptide contributes to homodimerization of the TRPV4 N terminus. (A) The purified and biotinylated N2-GST protein was
subjected to SDS-PAGE, blotted and visualized in avidin-peroxidase overlay experiments. In addition to the monomeric form at 34.8 kD, a second
band at a size consistent with that of the N2 dimer was detected. (B) The P2 peptide interacts with the wild type N2 fragment and the WIA but not the
KRA mutant. In an AlphaScreen experiment, biotinylated P2 peptide was subjected to interaction with wild type N2 fragment (wt) or the mutants WIA
or KRA at the indicated concentrations. (C) The full-length TRPV4 N termini show dimerization in FRET acceptor bleaching experiments. (p,0.0001, 4
and 3 independent experiments). (D) The interaction between P2-biotin and C2-Flag is inhibited by the C2 fragment with a 3.5-fold lower IC50 than
the N2 fragment. (E) The complex between CaM-biotin and C2-Flag at 100 mMC a
2+ is inhibited by C2 with a 14-fold higher affinity than by N2.
doi:10.1371/journal.pone.0010580.g007
Figure 8. Proposed TRPV4 potentiation mechanism. (A) In the
resting state, an N-terminal site (filled box) binds to a C-terminal domain
(open box) thus permitting only weak channel activation. The hatched
lines in the fourth transmembrane region are meant to indicate that the
interaction can occur between channel subunits or possibly within a
channel subunit. (B) Increase of the intracellular calcium concentration
to micromolar concentrations leads to Ca
2+/CaM binding to the C-
terminal site and displacement of the N-terminal interaction site. The
corresponding conformational change induces further increase in
channel activity. In the potentiated state, the N-terminal binding site
may form a homologous interaction with a second channel subunit.
doi:10.1371/journal.pone.0010580.g008
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in buffers containing 50 mM Tris, pH 7.5, 100 mM KCl, 0.1%
BSA and calcium at the indicated concentrations. Calcium
concentrations below 50 mM were buffered with HEDTA, EGTA
or EDTA at a buffer concentration of 10 mM. CaM concentra-
tions were 10 mM or as indicated; the tracer peptide concentration
was 100 nM. Fluorescence anisotropy was measured in a 384-well
black multititer plate (Fluotrac 200, Greiner) using a Fusion alpha
FP instrument (PerkinElmer) at 1 s reading time per well.




with Ipar and Iperp as the fluorescence emission intensities in planes
parallel and perpendicular to the excitation plane. FP signals are
given as mean6SEM of triplicate measurements in milli-P (mP)
units.
GFP-FRET in vivo interaction
Single-cell GFP-FRET was measured in a fluorescence imaging
system. Excitation of donor (CFP) and acceptor (YFP) fluorescence
was at 430 nm and 520 nm, respectively. After baseline recording,
the acceptor fluorescence was selectively photobleached by 30
cycles of 5 s expositions at 520 nm while measuring the donor and
acceptor fluorescences. Both channels were normalized to the
emission intensity immediately before acceptor bleaching. (See
Methods S1 for details).
Electrophysiology
Patch clamp recordings were performed on HEK293 cells in the
whole cell configuration. Cells were clamped at a potential of
220 mV, and current-voltage (I–V) relations were obtained from
voltage ramps from 2100 mV to +100 mV. The standard
extracellular solution contained 140 mM NaCl, 5 mM CsCl,
2 mM CaCl2, 1 mM MgCl2, 10 mM glucose, and 10 mM
HEPES (pH 7.4 with NaOH). In nominally Ca
2+-free solutions,
Ca
2+ was omitted. The standard intracellular solution contained
110 mM cesium methanesulfonate, 25 mM CsCl, 2 mM MgCl2,
0.362 mM CaCl2, 1 mM EGTA, and 30 mM HEPES (pH 7.2
with CsOH) with a calculated [Ca
2+] of 100 nM. (See Methods S1
for details).
Supporting Information
Methods S1 Supplementary Methods.
Found at: doi:10.1371/journal.pone.0010580.s001 (0.04 MB
DOC)
Figure S1 AlphaScreen-based CaM interaction assay. Strepta-
vidin-coated AlphaScreen donor- and anti-Flag-coated acceptor
beads were incubated with the indicated concentrations of CaM-
biotin and 6 nM C2-Flag (A) or C2-Flag and 10 nM CaM-biotin
(B). Data points show mean6SEM of measurements in buffer
containing 100 mMC a
2+ (filled squares) or 1 mM EGTA (open
squares). The AlphaScreen output signal is shown in arbitrary
units (kilo counts per second, kcps).
Found at: doi:10.1371/journal.pone.0010580.s002 (0.07 MB
TIF)
Figure S2 Ca
2+-dependent binding of C2 to CaM or CaM
mutants that are partially Ca
2+-binding defective. The Ca
2+-
dependence of C2-biotin binding to wild type CaM-Flag or
mutants that are Ca
2+-binding deficient in the N lobe (CaM12), the
C lobe (CaM34) or both lobes (CaM1234) was measured in an
AlphaScreen assay at the indicated Ca
2+ concentrations. Half
maximal binding was observed at 8.861.0 mM, 10.761.0 mM,
27.061.1 mMC a
2+ for CaM, CaM12 and CaM34, respectively
with a common hill coefficient of 2.0 (n=3 independent
experiments in triplicate). CaM1234 did not show measurable C2
interaction. To demonstrate the Ca
2+-independence of the assay
system itself, a GST-Flag-biotin fusion protein was incubated with
the AlphaScreen beads at 100 mMC a
2+ or 1 mM EGTA (inset).
The AlphaScreen readout was independent of the Ca
2+ concen-
tration.
Found at: doi:10.1371/journal.pone.0010580.s003 (0.07 MB
TIF)
Figure S3 Identification of CaM binding and interdomain
interaction sites in TRPV4. (A) A library of 20-mer peptides
overlapping by 18 amino acids and covering the TRPV4 N
terminus was spotted on filter paper and probed with biotinylated
CaM or C2 at 100 mMC a
2+. The peptide dots are shown at the
start of the respective 20-mer peptide within the TRPV4 sequence
graph. Thus, the underlying peptide sequence actually extends 20
amino acids, corresponding to 10 dots, to the right. The positions
of the ankyrin domains, the fragments N2 and N3 and peptides
P1, P2 and P3 are indicated. (B) Peptide library of the TRPV4 C
terminus, probed with biotinylated CaM or N2 fragment. The
positions of the C2-fragment and peptides P4 and P5 are
indicated.
Found at: doi:10.1371/journal.pone.0010580.s004 (0.31 MB
TIF)
Figure S4 CaM binding in the CaM interaction sites in TRPV4.
(A–E), In fluorescence polarization experiments, the carboxyfluor-
escein-labeled peptides P1 (A), P2 (B), P3 (C), P4 (D) and P5 (E)
were incubated with CaM, CaM mutants or isolated CaM lobes
(see Fig. 1B in main text) at concentrations between 0.1 nM and
10 mM. The respective EC50 values are given in Table S2.
Found at: doi:10.1371/journal.pone.0010580.s005 (0.11 MB
TIF)
Figure S5 The N2 fragment forms dimers in gel filtration
experiments. (A) N2 results in a monophasic elution profile with an
apparent molecular size that corresponds with a dimeric form of
the protein. (B) Calibration was done with a commercial protein
mixture with the indicated molecular weights.
Found at: doi:10.1371/journal.pone.0010580.s006 (0.07 MB
TIF)
Table S1 Positions of the TRPV4 fragments used in the study.
Found at: doi:10.1371/journal.pone.0010580.s007 (0.03 MB
DOC)
Table S2 CaM binding properties of the putative CaM
interaction peptides.
Found at: doi:10.1371/journal.pone.0010580.s008 (0.03 MB
DOC)
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